The Food and Drug Administration (FDA) has approved a new freeze-dried formulation of Jynneos ® (smallpox and mpox vaccine, live, non-replicating). Prior to this approval, Jynneos had only been ...

March 31 (Reuters) - Denmark's Bavarian Nordic , opens new tab said on Monday the U.S. Food and Drug Administration has approved a freeze-dried formulation of its mpox and smallpox vaccine.

Exercised options total USD 143.6 million Secures manufacturing and supply of freeze-dried JYNNEOS ® to the U.S. in 2026 COPENHAGEN, Denmark, May 6, 2025– Bavarian Nordic A/S announced today ...

COPENHAGEN, Denmark, March 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) today announced that the U.S. Food and Drug Administration (FDA) has approved the freeze-dried formulation of JYNNEOS ...

A randomized phase 3 trial to assess the immunogenicity and safety of 3 consecutively produced lots of freeze-dried MVA-BN® vaccine in healthy adults. Vaccine. Published online January 9, 2023 ...